
Externally-Led Patient Focused Drug Development Meeting on CIDP
Friday, March 25, 2022
The GBS|CIDP Foundation International is leading the effort to characterize the patient journey and bring the patient voice into the drug development process. We will continue to utilize a patient-reported information registry and robust support and education programming to accurately describe the patient experience that also encourages self-advocacy in both clinical and research settings. The Foundation hopes that an externally-led Patient Focused Drug Development meeting will elevate the CIDP patient voice and increase understanding of patients’ preferences when it comes to tolerable side effects, most hindering symptoms of CIDP, and a better understanding of the progressive disability associated with poorly managed CIDP. Ultimately, the Foundation aims to bring the patient voice into the drug development process.
Join us on Friday, March 25th, 2022 for the Virtual Voice of the Patient Summit. All times listed reflect Eastern Standard Time Zone (EST).
Meet the Patient Panel
Diagnosis and Current Treatment for CIDP

Everyday Burden of CIDP

Patient Centered Trial Design

Potential Future of CIDP Treatment

Thank You to Our Sponsors!
